Protein IGFBP6 plays an important role in the pathogenesis of many malignant tumors, including breast cancer. The relationship between IGFBP6 protein and the expression of genes associated with the epithelial-mesenchymal transition is studied. Gene IGFBP6 knockdown does not trigger the epithelial-mesenchymal transition in MDA-MB-231 cells, but modifies significantly the expression of many genes involved in this process. A decrease of IGFBP6 expression can involve a decrease in the expression of N-cadherin and transcription factor Slug.
Similar content being viewed by others
References
Bach LA. Current ideas on the biology of IGFBP-6: More than an IGF-II inhibitor? Growth Horm IGF Res. 2016;30-31):81-86.
Bach LA, Fu P, Yang Z. Insulin-like growth factor-binding protein-6 and cancer. Clin. Sci. (Lond). 2013;124(4):215-229.
Chen Q, Qin S, Liu Y, Hong M, Qian CN, Keller ET, Zhang J, Lu Y. IGFBP6 is a novel nasopharyngeal carcinoma prognostic biomarker. Oncotarget. 2016;7(42):68 140-68 150.
Galatenko VV, Shkurnikov MY, Samatov TR, Galatenko AV, Mityakina IA, Kaprin AD, Schumacher U, Tonevitsky AG. Highly informative marker sets consisting of genes with low individual degree of differential expression. Sci. Rep. 2015;5. ID 14967. doi: 10.1038/srep14967.
Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 2014;15(3):178-196.
Malaguarnera R, Belfiore A. The emerging role of insulin and insulin-like growth factor signaling in cancer stem cells. Front. Endocrinol. (Lausanne). 2014;5:10. doi: 10.3389/fendo.2014.00010.
Moreno-Bueno G, Cubillo E, Sarrió D, Peinado H, Rodríguez-Pinilla SM, Villa S, Bolós V, Jordá M, Fabra A, Portillo F, Palacios J, Cano A. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for snail, slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res. 2006;66(19):9543-9556.
Schwankhaus N, Gathmann C, Wicklein D, Riecken K, Schumacher U, Valentiner U. Cell adhesion molecules in metastatic neuroblastoma models. Clin. Exp. Metastasis. 2014;31(4):483-496.
Semenova OV, Petrov VA, Gerasimenko TN, Aleksandrova AV, Burmistrova OA, Khutornenko AA, Osipyants AI, Poloznikov AA, Sakharov DA. Effect of circulation parameters on functional status of HepaRG spheroids cultured in microbioreactor. Bull. Exp. Biol. Med. 2016;161(3):425-429.
Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Mol. Cancer. 2016;15:18. doi: https://doi.org/10.1186/s12943-016-0502-x.
Tiwari N, Meyer-Schaller N, Arnold P, Antoniadis H, Pachkov M, van Nimwegen E, Christofori G. Klf4 is a transcriptional regulator of genes critical for EMT, including Jnk1 (Mapk8). PLoS One. 2013;8(2):e57329. doi: https://doi.org/10.1371/journal.pone.0057329.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global Cancer Statistics, 2012. CA Cancer J. Clin. 2015;65(2):87-108.
Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011;147(2):275-292.
Wang Y, Zhou BP. Epithelial-mesenchymal transition in breast cancer progression and metastasis. Chin. J. Cancer. 2011;30(9):603-611.
Zeng C, Feng X, Wang W, Lv L, Fang C, Chi L, Huang L, Zhou Z. Decreased expression of insulin-like growth factor binding protein 6 is associated with gastric adenocarcinoma prognosis. Oncol. Lett. 2017;13(6):4161-4168.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 164, No. 11, pp. 605-610, November, 2017
Rights and permissions
About this article
Cite this article
Nikulin, S.V., Raigorodskaya, M.P., Poloznikov, A.A. et al. Role of IGFBP6 Protein in the Regulation of Epithelial-Mesenchymal Transition Genes. Bull Exp Biol Med 164, 650–654 (2018). https://doi.org/10.1007/s10517-018-4051-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-018-4051-8